Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 1
2014 1
2015 2
2016 1
2017 2
2021 1
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
6-Aryl-quinazolines as novel GABAB receptor positive allosteric modulators.
Huszár J, Petró JL, Hadady Z, Bobok AÁ, Sághy K, Halász AS, Hornyánszky G, Román V, Greiner I, Éles J. Huszár J, et al. Among authors: bobok aa. Bioorg Med Chem Lett. 2022 Jul 1;67:128714. doi: 10.1016/j.bmcl.2022.128714. Epub 2022 Apr 1. Bioorg Med Chem Lett. 2022. PMID: 35367591
Multiparameter Optimization of Naphthyridine Derivatives as Selective α5-GABAA Receptor Negative Allosteric Modulators.
Szabó G, Éliás O, Erdélyi P, Potor A, Túrós GI, Károlyi BI, Varró G, Vaskó ÁG, Bata I, Kapus GL, Dohányos Z, Bobok AÁ, Fodor L, Thán M, Vastag M, Komlódi Z, Soukupné Kedves RÉ, Makó É, Süveges B, Greiner I. Szabó G, et al. Among authors: bobok aa. J Med Chem. 2022 Jun 9;65(11):7876-7895. doi: 10.1021/acs.jmedchem.2c00414. Epub 2022 May 18. J Med Chem. 2022. PMID: 35584373
Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein Structure.
Krámos B, Hadady Z, Makó A, Szántó G, Felföldi N, Magdó I, Bobok AÁ, Bata I, Román V, Visegrády A, Keserű GM, Greiner I, Éles J. Krámos B, et al. Among authors: bobok aa. ACS Med Chem Lett. 2024 Mar 1;15(3):396-405. doi: 10.1021/acsmedchemlett.3c00560. eCollection 2024 Mar 14. ACS Med Chem Lett. 2024. PMID: 38505850
Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.
Wágner G, Wéber C, Nyéki O, Nógrádi K, Bielik A, Molnár L, Bobok A, Horváth A, Kiss B, Kolok S, Nagy J, Kurkó D, Gál K, Greiner I, Szombathelyi Z, Keseru GM, Domány G. Wágner G, et al. Among authors: bobok a. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3737-41. doi: 10.1016/j.bmcl.2010.04.075. Epub 2010 Apr 22. Bioorg Med Chem Lett. 2010. PMID: 20483612
Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.
Galambos J, Bielik A, Krasavin M, Orgován Z, Domány G, Nógrádi K, Wágner G, Balogh GT, Béni Z, Kóti J, Szakács Z, Bobok A, Kolok S, Mikó-Bakk ML, Vastag M, Sághy K, Laszy J, Halász AS, Balázs O, Gál K, Greiner I, Szombathelyi Z, Keserű GM. Galambos J, et al. Among authors: bobok a. J Med Chem. 2017 Mar 23;60(6):2470-2484. doi: 10.1021/acs.jmedchem.6b01858. Epub 2017 Mar 1. J Med Chem. 2017. PMID: 28212015
Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists.
Galambos J, Wágner G, Nógrádi K, Bielik A, Molnár L, Bobok A, Horváth A, Kiss B, Kolok S, Nagy J, Kurkó D, Bakk ML, Vastag M, Sághy K, Gyertyán I, Gál K, Greiner I, Szombathelyi Z, Keseru GM, Domány G. Galambos J, et al. Among authors: bobok a. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4371-5. doi: 10.1016/j.bmcl.2010.06.075. Epub 2010 Jun 17. Bioorg Med Chem Lett. 2010. PMID: 20615697
15 results